CHME — China Medicine Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for China Medicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2005 December 31st	2006 December 31st	2007 December 31st	2008 December 31st	2009 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10KSB	10KSB	10KSB	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	5.69	4.79	6.88	9.13	1.72
Depreciation
Deferred Taxes
Non-Cash Items	-0.408	0.789	0.583	0.016	7.12
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-4.21	-7.96	-10.1	-5.35	7.11
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	1.17	-2.22	-2.31	4.21	17
Capital Expenditures	-0.167	-0.827	-0.39	-2.67	-3.67
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0.613	0	0	-5.2	-9.86
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities	0.446	-0.827	-0.39	-7.86	-13.5
Financing Cash Flow Items	-1.89	-0.2	0	0	-1.76
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1.8	3.49	7.83	0.363	-5.75
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.152	0.28	5.4	-2.98	-2.32